resveratrol has been researched along with Leukemia, Promyelocytic, Acute in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbadessa, V; Di Cristina, A; Gebbia, N; Grimaudo, S; Pizzirani, D; Recanatini, M; Roberti, M; Simoni, D; Tolomeo, M | 1 |
| Kmiec, Z; Siedlecka-Kroplewska, K; Wozniak, M | 1 |
| Feng, L; Li, B; Li, F; Liu, Y; Shi, Y; Wang, J; Yan, M | 1 |
| Chen, M; Fan, Y; Fang, K; Meng, J; Tu, Y; Wan, L; Yu, L; Zhu, W | 1 |
| Komina, O; Wesierska-Gadek, J | 1 |
| Jeong, NY; Jeong, SH; Kim, TH; Kwon, TK; Lee, JS; Park, BS; Song, S; Suh, H; Yoo, KS; Yoo, YH | 1 |
| Chang, L; Chiu, J; He, S; Li, G; Lu, H; Zhang, H | 1 |
| Cao, D; Guo, K; He, Y; Hu, L; Li, Y | 1 |
| Bauer, W; Erker, T; Fritzer-Szekeres, M; Hoechtl, T; Horvath, Z; Illmer, C; Jaeger, W; Madlener, S; Saiko, P; Szekeres, T | 2 |
| Cao, Y; Fu, ZD; Han, R; Liu, HY; Wang, F | 1 |
| Erker, T; Fritzer-Szekeres, M; Grusch, M; Handler, N; Horvath, Z; Jaeger, W; Krupitza, G; Madlener, S; Murias, M; Saiko, P; Szekeres, T | 1 |
| Bonnesen, C; Stervbo, U; Vang, O | 1 |
| Hurh, YJ; Kang, JY; Kong, G; Lee, E; Lee, SJ; Surh, YJ | 1 |
14 other study(ies) available for resveratrol and Leukemia, Promyelocytic, Acute
| Article | Year |
|---|---|
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Differentiation; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Fusion Proteins, bcr-abl; G1 Phase; Humans; Leukemia, Promyelocytic, Acute; Resting Phase, Cell Cycle; Resveratrol; Stilbenes; Structure-Activity Relationship; Terphenyl Compounds | 2006 |
The wine polyphenol resveratrol modulates autophagy and induces apoptosis in MOLT-4 and HL-60 human leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Cell Line, Tumor; Cell Survival; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Membrane Potential, Mitochondrial; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Reactive Oxygen Species; Resveratrol; Wine | 2019 |
Mechanism of As2O3-Induced Action Potential Prolongation and Using hiPS-CMs to Evaluate the Rescue Efficacy of Drugs With Different Rescue Mechanism.
Topics: Action Potentials; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; ERG1 Potassium Channel; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Leukemia, Promyelocytic, Acute; Long QT Syndrome; Lysosomes; Myocytes, Cardiac; Oxides; Patch-Clamp Techniques; Proteolysis; Resveratrol; Stilbenes; Terfenadine | 2017 |
Arsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Leukemia, Promyelocytic, Acute; Myocytes, Cardiac; Neoplasm Proteins; Oxides; Rats; Reactive Oxygen Species; Resveratrol; Stilbenes; Superoxide Dismutase | 2014 |
Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells.
Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinases; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Phosphorylation; Protein Kinase Inhibitors; Purines; Resveratrol; Roscovitine; Stilbenes | 2008 |
A novel resveratrol analogue HS-1793 treatment overcomes the resistance conferred by Bcl-2 and is associated with the formation of mature PML nuclear bodies in renal clear cell carcinoma Caki-1 cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Humans; Intranuclear Inclusion Bodies; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Membrane Potential, Mitochondrial; Microscopy, Confocal; Naphthols; Nuclear Proteins; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-bcl-2; Resorcinols; Resveratrol; Stilbenes; Transcription Factors; Tumor Suppressor Proteins | 2009 |
GADD45α and annexin A1 are involved in the apoptosis of HL-60 induced by resveratrol.
Topics: Annexin A1; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Cycle Proteins; Cell Growth Processes; Cell Survival; DNA Damage; G1 Phase; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Resting Phase, Cell Cycle; Resveratrol; Stilbenes | 2011 |
Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Cytokine-Induced Killer Cells; Cytotoxicity, Immunologic; Gene Expression Regulation, Leukemic; GPI-Linked Proteins; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-15; Interleukin-2; Intracellular Signaling Peptides and Proteins; Leukemia, Promyelocytic, Acute; Leukocytes, Mononuclear; Ligands; NK Cell Lectin-Like Receptor Subfamily K; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor, Member 10c; Resveratrol; Stilbenes; Tumor Necrosis Factor Decoy Receptors | 2012 |
Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Differentiation; Cytarabine; Deoxyribonucleotides; DNA; Drug Synergism; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Resveratrol; Ribavirin; Ribonucleotide Reductases; Stilbenes | 2005 |
Resveratrol induces apoptosis and differentiation in acute promyelocytic leukemia (NB4) cells.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Proliferation; DNA Damage; Humans; Leukemia, Promyelocytic, Acute; Resveratrol; Stilbenes; Tretinoin; Tumor Cells, Cultured | 2005 |
Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cytarabine; Deoxyribonucleotides; Drug Evaluation, Preclinical; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; NF-kappa B; Pyrogallol; Resveratrol; Ribonucleotide Reductases; Ribonucleotides; Stilbenes; Tumor Necrosis Factor-alpha; Wine | 2006 |
Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cytarabine; Drug Screening Assays, Antitumor; Drug Synergism; Free Radical Scavengers; Free Radicals; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Resveratrol; Ribavirin; Stilbenes | 2006 |
Time- and concentration-dependent effects of resveratrol in HL-60 and HepG2 cells.
Topics: Annexin A5; Anticarcinogenic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Nucleus Size; DNA Fragmentation; Dose-Response Relationship, Drug; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Liver Neoplasms; Resveratrol; Stilbenes; Thymidine; Tritium | 2006 |
Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells.
Topics: Anticarcinogenic Agents; Antioxidants; Apoptosis; Cell Division; Cell Nucleus; Cell Survival; DNA; DNA Fragmentation; Electrophoresis, Agar Gel; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Microscopy, Electron; Proto-Oncogene Proteins c-bcl-2; Resveratrol; Stilbenes; Time Factors | 1999 |